TRIPLEMED
TripleMed is developing minimally invasive products against aneurysms, without the need for incisions. The first product fills the aneurysm and prevents blood from entering, whilst leaving a channel for the blood to flow through to reach the other arteries. This enables a better and longer-lasting solution to the problem of aortic aneurysms.
TRIPLEMED
Industry:
Biotechnology Health Care Product Research
Founded:
2011-01-01
Address:
Maastricht, Limburg, The Netherlands
Country:
The Netherlands
Website Url:
http://www.triplemedical.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Content Delivery Network Wix Wix Media
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
Benvenue Medical
Benvenue Medical is a biotech company developing innovative and minimally invasive surgical solutions for the treatment of spinal disorders.
BioEcho Life Sciences
BioEcho develops innovative products that drastically improve the quality, convenience, and speed of standard molecular biology.
Brighter
Data-driven solutions for smarter treatment of chronic conditions.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Sesen Bio, Inc.
Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
Laytrix
Laytrix Limited develops equipment for laying and removing subsea pipelines.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
T-Maximum
T-Maximum develops CAR-T cell therapies for the treatment of brain tumors.
Current Employees Featured
Founder
Investors List
Chemelot Ventures
Chemelot Ventures investment in Series A - TripleMed
Limburg Business Development Fund (LBDF)
Limburg Business Development Fund (LBDF) investment in Series A - TripleMed
Official Site Inspections
http://www.triplemedical.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "TripleMed"
ABOUT - triplemed
TripleMed was founded in 2011 by 3 reputed vascular surgeons: Brom, de Vries and Jacobs, and is located on the Chemelot Campus in Geleen, the Netherlands.See details»
TripleMed - Crunchbase Company Profile & Funding
Contact Email [email protected] TripleMed is developing minimally invasive products against aneurysms, without the need for incisions. The first product fills the aneurysm and …See details»
TripleMed Company Profile 2024: Valuation, Funding & Investors
TripleMed General Information Description. Developer of minimally invasive products designed to focus on the treatment of aortic aneurysms. The company's products consist of an elastic …See details»
TripleMed - Products, Competitors, Financials, Employees, …
Triplemedical.com. Overview & Products; Financials; People; Founded Year 2011. Stage Series B | Alive. Total Raised $4.57M. Last Raised $2.18M | 8 mos ago. About TripleMed. TripleMed …See details»
TripleMed Company Profile - Office Locations, Competitors ... - Craft
TripleMed has 1 employees at their 1 location and $2.39 m in total funding,. See insights on TripleMed including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
TripleMed - Overview, News & Similar companies | ZoomInfo.com
View TripleMed (www.triplemedical.com) location in Limburg, Netherlands , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
TripleMed BV - Drug pipelines, Patents, Clinical trials - Synapse
Explore TripleMed BV with its drug pipeline, therapeutic area, technology platform, .See details»
TripleMed - Brightlands Venture Partners
See www.TripleMedical.com. Subscribe to our newsletter. First name * Last name * Company * Email * Visiting address. Center Court 1026 Brightlands Chemelot Campus Urmonderbaan 22 …See details»
Triplemed Information - RocketReach
TripleMed was founded in 2011 by 3 reputed vascular surgeons, Brom, De Vries and Jacobs. Their aim is to develop innovative and cost-effective solutions for the treatment of aortic …See details»
TripleMed CEO and Key Executive Team | Craft.co
TripleMed's Chief Medical Officer is Hans Brom. Other executives include Tjeerd Homsma, Chief Executive Officer; Sjaak Deckers, Chairman and 2 others. See the full leadership team at Craft.See details»
Funding for TripleMed to achieve CE marking
Mar 21, 2024 More information: www.triplemedical.com. About Brightlands Venture Partners Brightlands Venture Partners (BVP) is the fund manager of Chemelot Ventures and is a so …See details»
MISSION / VISION - triplemed
Since 2000 the treatment of Abdominal Aortic Aneurysms has been revolutionized with the introduction of the EVAR endograft. The first endografts demonstrated a large reduction in …See details»
Triple Medical Company Profile | San Diego, CA | Competitors ...
See other industries within the Health Care and Social Assistance sector: Child Care Services , Community Food and Housing, and Emergency and Other Relief Services , Continuing Care …See details»
Groundbreaking treatment for type II endoleaks proves very …
Jun 7, 2021 Voor verdere informatie zie www.triplemedical.com. Subscribe to our newsletter. First name * Last name * Company * Email * Visiting address. Center Court 1026 Brightlands …See details»
Funding for TripleMed to achieve CE marking - LIOF
TripleMed BV is a medical startup focused on improving the treatment of aortic aneurysms. A consortium of existing and new investors has contributed more than two million euros to …See details»
Why Canada excels at medical tech startups - The Globe and Mail
1 day ago The incubator program at the University of Toronto’s Mississauga campus – which opened its doors to its first 15 startups in the first cohort in May – is one of the few in Canada …See details»
CLINICAL EVIDENCE - triplemed
© 2018 TripleMed • All rights reserved • Design by Brightlands Maastricht Health CampusSee details»
Three Branches Medical
Please book a follow-up appointment after you complete your tests as we may not have received your results. Thank you for your patience and support. We look forward to welcoming you to …See details»
NEWS - triplemed
After obtaining METC approval in 2020 and a positive DSMB review for the type II Endoleak study, the pilot clinical study to treat patients with a high risk of developing type II Endoleaks …See details»
TECHNOLOGY - triplemed
The AneuFix / AneuFill polymer mix is tuned to cure in several minutes to give the physician ample time to fill the void in a controlled fashion, be it the endoleak or the complete aneurysm …See details»